CQC Medicines Optimisation

Add to CPD Start a discussion
Under Review — this page was due to be reviewed by 21 November 2025. The information shown here may be outdated.

To provide an outline of the evidence for CQC Medicines Optimisation (MO) requirements and support to enable practices to meet the CQC inspection requirements. This will cover; Responsibilities and accountabilities Policies and processes High risk medicine monitoring Medicines safety: Acting on safety alerts Long term condition management Medication Reviews Clinical supervision.



Broadcast date: November 10th, 2023
Review date: Nov 21st, 2025